Enact Holdings Inc.

Enact Holdings Inc. (ACT) Market Cap

Enact Holdings Inc. has a market capitalization of $6.61B.

Price: $47.32

-0.17 (-0.36%)

Market Cap: 6.61B

NASDAQ · time unavailable

CEO: Rohit Gupta

Sector: Financial Services

Industry: Insurance - Property & Casualty

IPO Date: 2021-09-16

Website: https://www.enactmi.com

Enact Holdings Inc. (ACT) - Company Information

Market Cap: 6.61B|Sector: Financial Services

Company Profile

Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company engages in writing and assuming residential mortgage guaranty insurance. It also offers private mortgage insurance products insuring prime-based, individually underwritten residential mortgage loans; pool mortgage insurance; contract underwriting services; and mortgage-related reinsurance products. The company serves large money center banks, non-bank lenders, national and local mortgage bankers, community banks, and credit unions. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. is a subsidiary of Genworth Holdings Inc.

Analyst Sentiment

57%
Buy

From 5 Active Polls

1Y Forecast: $48.00

▲ +1.4% Potential Upside

Consensus Target Metrics

Low Bound

$46

Median

$48

High Bound

$50

Average

$48

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$48.00
▲ +1.44% Upside
Low Target
$46.00
-3% Risk
Median Target
$48.00
1% Mid
High Target
$50.00
6% Max
Consensus
Hold
3 / 8 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)6,6065,7785,7205,6535,5705,2764,9725,6524,875
Enterprise Value ($M)6,8025,9745,8825,8535,7015,3845,1325,7214,918
Price to Earnings Ratio (P/E)10.208.658.068.648.297.977.647.836.63
Price/Earnings-to-Growth Ratio (PEG)47.92482.573.854.852.182.67
Price to Sales Ratio (P/S)5.3318.5218.3618.1518.2917.1916.4718.2616.31
Price to Book Ratio (P/B)1.251.081.071.061.071.031.001.121.01
Price to Free Cash Flow Ratio (P/FCF)9.1525.7930.7129.4446.6123.2729.9330.0433.69
Enterprise Value to Sales (EV/Sales)19.1418.8818.7918.7217.5417.0018.4816.46
Enterprise Value to EBITDA (EV/EBITDA)7.4726.4624.9726.2825.1424.0723.3223.6619.56
Debt to Equity Ratio0.210.140.140.140.140.150.150.150.15

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 ENACT HOLDINGS INC (ACT) — Investment Overview

🧩 Business Model Overview

ENACT HOLDINGS INC is a U.S. property and casualty insurance carrier. The business model follows a classic underwriting + investment framework: ENACT assumes risk from policyholders in exchange for premium, prices that risk using underwriting models and historical loss experience, and manages ongoing policy and claims operations to control loss severity and expense levels. Earned premium is generated as coverage is provided over the policy term, while investment income is earned on the firm’s capital and insurance “float” (technical reserves and surplus held to pay future claims).

A practical way to view ENACT’s operating cycle is: (1) source risk through distribution channels (primarily independent agents and broker relationships), (2) underwrite and price for an acceptable risk-adjusted return, (3) control claims through triage, adjuster strategy, and legal/medical cost management, and (4) invest the insurance balance sheet to support profitability while maintaining liquidity and capital adequacy.

💰 Revenue Streams & Monetisation Model

ENACT’s monetisation is driven by three recurring components typical for insurers:

  • Premiums earned: The main operating revenue, recognized as coverage is provided. Underwriting discipline determines whether premium translates into durable underwriting profit.
  • Net investment income: Income earned on invested assets supporting reserves and surplus. The spread between asset yields and the implied cost of liabilities is a key contributor to total earnings power.
  • Other income / hedge and investment-related items: Results can include non-operating or periodically recognized items that affect earnings volatility, but long-run performance still depends on underwriting margin and investment results.

The primary margin drivers are underwriting loss ratio outcomes (frequency/severity and catastrophe exposure), expense efficiency (acquisition, commissions, general and administrative costs), and the ability to maintain rate adequacy over the cycle. Claims handling quality and reserving accuracy influence the translation of premium into earnings.

🧠 Competitive Advantages & Market Positioning

ENACT’s moat is best framed as underwriting and risk selection discipline—a form of intangible, hard-to-copy capability that affects long-run loss outcomes and underwriting profitability. While insurance products are substitutable, profitable underwriting depends on data, modeling, pricing governance, claims cost control, and the ability to maintain capital discipline across loss regimes. This aligns to a regulatory moat + risk culture: as a licensed carrier, ENACT competes within regulatory constraints while needing credible actuarial/reserving practices and sufficient capital to stay solvent through adverse periods.

Competitive benchmarking:

  • Progressive: broad personal auto presence with aggressive pricing and large-scale data and technology investments. Enact competes more as a specialty-focused carrier, where risk selection and underwriting governance matter more than pure scale.
  • Allstate: strong brand distribution and multi-line platform (home, auto, protection products). Enact’s positioning depends less on mass-market distribution and more on managing complex risk profiles through pricing and claims strategy.
  • Nationwide: diversified insurance portfolio and broad distribution footprint. Enact’s differentiation is tied to maintaining an underwriting “fit” for the classes it chooses rather than matching Nationwide’s breadth.

Moat summary: competitors can copy distribution and coverage offerings more easily than they can replicate consistent underwriting outcomes. ENACT’s advantage is rooted in the internal process: pricing rigor, underwriting appetite discipline, claims cost management, and reserving credibility—factors that are difficult for new entrants or less disciplined carriers to match over multiple cycles.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, ENACT’s growth and earnings compounding are most plausibly driven by:

  • Rate/terms alignment and portfolio optimization: Sustained underwriting profitability improves when premium reflects actual risk, supported by disciplined renewals and selective growth in lines where loss experience is controllable.
  • Claims cost management: Better claims triage, vendor strategy, litigation controls, and rehabilitation pathways reduce loss severity and volatility.
  • Operational expense leverage: Over time, improved automation, better claims workflows, and scale within administrative functions can improve expense ratios even without broad market share gains.
  • Reinsurance and capital strategy: Using reinsurance structures and capital allocation to manage tail risk can stabilize underwriting results and support consistent written premium.
  • Float and investment balance sheet management: Maintaining asset quality and duration choices that fit liability characteristics supports steady investment contribution across economic regimes.

Because insurance is a “cycle business,” the durable driver is not volume growth alone, but the capacity to grow with appropriate risk-adjusted returns while maintaining solvency and reserve adequacy.

⚠ Risk Factors to Monitor

  • Catastrophe and severity risk: Unexpected loss severity, weather-driven events, and accumulation risk can pressure underwriting results and increase capital needs.
  • Reserve adequacy and reserving model risk: Errors in loss reserving or deteriorating trends can cause earnings volatility and require unfavorable reserve development.
  • Pricing and competition risk: If market competition forces pricing below loss expectations, underwriting margin can compress and take time to correct.
  • Interest rate and investment risk: Changes in yield curves and asset default risk affect investment income and the overall earnings contribution from the balance sheet.
  • Regulatory and compliance risk: Insurance regulation can influence underwriting practices, reserving standards, capital requirements, and product constraints.
  • Model risk and data quality: Pricing/claims analytics can fail due to shifts in loss drivers, fraud patterns, or data degradation.

📊 Valuation & Market View

Insurance equity is typically valued less on short-term earnings and more on book value quality and compounding. Market participants usually focus on:

  • Book value growth and return on equity (ROE) durability driven by underwriting cycle management
  • Underwriting profitability indicators (combined ratio components: loss ratio and expense ratio) rather than purely growth in written premium
  • Investment contribution stability and the resilience of net investment income under different rate environments
  • Capital adequacy and capital deployment (dividends/buybacks versus maintaining surplus for solvency)

Key valuation drivers move with the credibility of underwriting margin, reserving outcomes, and the sustainability of investment income consistent with risk appetite and regulatory constraints.

🔍 Investment Takeaway

ENACT HOLDINGS INC’s long-term opportunity rests on its ability to sustain profitable underwriting through risk selection discipline, credible reserving practices, and effective claims-cost management—supported by the balance-sheet role of float and investment income. The core thesis is that insurance share is “earned” through repeatable underwriting outcomes across loss regimes, not through product similarity or short-term growth.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for ACT.

prnewswire.com2026-07-30

ACT Capital Advisors Secures Development Capital from Pathward and BridgePeak for Teichos Energy's Late-Stage Solar Energy Projects

SEATTLE, July 30, 2026 /PRNewswire/ -- ACT Capital Advisors today announced that it has secured $30 million in development line financing from Pathward®, N.A. on behalf of Teichos Energy, LLC, a utility-scale renewable energy developer.

zacks.com2026-07-29

Enact Holdings, Inc. (ACT) Reports Next Week: Wall Street Expects Earnings Growth

Enact Holdings (ACT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

globenewswire.com2026-07-16

Aduro and ECOCE Complete Phase 1 Feedstock Mapping, Advance Mexico Plastics Collaboration to HCT Testing

LONDON, Ontario, July 16, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that its collaboration with ECOCE, A.C.

globenewswire.com2026-07-09

Enact to Host Second Quarter 2026 Earnings Call August 6th

RALEIGH, N.C., July 09, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on August 5, 2026. Enact will host a conference call to review second quarter 2026 financial results on August 6, 2026 at 8:00 a.m. (ET).

globenewswire.com2026-06-24

OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE

FORM 8.1(a) & (b) (Opening Position Disclosure) IRISH TAKEOVER PANEL AUSTIN, TX, June 24, 2026 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ: FWDI) 1.    KEY INFORMATION (a)   Full name of discloser: Forward Industries, Inc. (b)   Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient.

globenewswire.com2026-06-24

Aduro Clean Technologies Announces Closing of LIFE Offering

LONDON, Ontario, June 24, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that, further to its previous news releases dated June 10, 2026 and June 15, 2026, it has completed a non-brokered private placement for gross proceeds of C$9,155,940.80 (US$6,564,810.21) from the sale of 431,884 common shares (the “LIFE Shares”) at a price of C$21.20 (US$15.20) per LIFE Share (the “LIFE Offering”) under the LIFE Exemption (as defined herein).

globenewswire.com2026-06-17

Aduro Clean Technologies Europe Signs MOU with Ortessa Groep BV to Advance FOAK Plant Feedstock Logistics

LONDON, Ontario, June 17, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that Aduro Clean Technologies Europe BV (“ACTE”), the Company's European subsidiary, has signed a non-binding memorandum of understanding (“MOU”) with Ortessa Groep BV (“Ortessa”), a Dutch group of enterprising waste companies, to evaluate the development of a feedstock logistics center to support Aduro's first-of-a-kind (“FOAK”) industrial site at Chemelot Industrial Park (“Chemelot”) in Sittard-Geleen, the Netherlands.

globenewswire.com2026-06-15

Aduro Clean Technologies Announces Filing of Amended and Restated LIFE Offering Document Following Closing of Public Offering

LONDON, Ontario, June 15, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that, further to its previous announcement dated June 10, 2026 of a non-brokered private placement of up to 471,698 common shares (the “Offered Shares”) at a price of $15.20 (C$21.20) per Offered Share for gross proceeds of up to US$7,169,810 (C$9,999,734)(the “LIFE Offering”), the Company has filed an amended and restated offering document (the “Amended and Restated LIFE Offering Document”) following the completion of its underwritten public offering as announced on June 11, 2026 (the “Public Offering”) in accordance with applicable securities laws. The LIFE Offering is expected to close on or about June 19, 2026 or such other date as the Company may determine, subject to applicable securities and the policies of the Toronto Stock Exchange (“TSX”).

globenewswire.com2026-06-11

Aduro Clean Technologies Announces Closing $15.54 Million Underwritten Public Offering

LONDON, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the closing of its underwritten U.S. and Canadian public offering (the “Public Offering”) of 1,028,645 common shares at a price of US$15.20 (C$21.20) per common share for gross proceeds to the Company of US$15,635,404, before deducting underwriting discounts and offering expenses.

globenewswire.com2026-06-10

Aduro Clean Technologies Announces Pricing of US$15.64 Million Underwritten Public Offering and Concurrent Private Placement of up to US$7.17 Million

Aduro announces pricing of up to US$22.81M offering, including a public offering and LIFE private placement to fund FOAK Plant, R&D and corporate purposes.

seekingalpha.com2026-06-07

Enact Holdings Continues To Be The Driver For Genworth Financial

Genworth Financial is maintained as a Buy, but with increased caution due to persistent challenges outside its Enact Holdings stake. GNW's valuation remains heavily discounted relative to its $4.7B ACT stake, while legacy long-term care and closed-block businesses continue to drag earnings. Shareholder value is driven by aggressive buybacks, with FY 2026 repurchases guided to $195–$225M and a potential $750M legal windfall pending appeal.

newsfilecorp.com2026-06-04

Aduro Clean Technologies Inc. (ACT) Opens the Market

Toronto, Ontario--(Newsfile Corp. - June 4, 2026) - Ofer Vicus, Chief Executive Officer and Co-Founder, Marc Trygstad, Principal Scientist and Co-Founder, David Weizenbach, Chief Operating Officer, and Mena Beshay, Chief Financial Officer of Aduro Clean Technologies Inc., as well as other team members, ("Aduro" or the "Company") (TSX: ACT), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange ("TSX"), to open the market to celebrate the Company's new listing to TSX. Cannot view this video?

prnewswire.com2026-05-29

Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs

Together the allowances deepen protection across two priority franchises and reinforce a patent estate of approximately 250 issued and pending patents and patent applications worldwide NEW YORK, May 29, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Canadian Intellectual Property Office (CIPO) has issued Notices of Allowance for two patent applications spanning the Company's Actimab-A and Iomab-ACT programs. The allowances broaden Actinium's intellectual property protection across both hematologic malignancies and next-generation conditioning for gene-edited cell-based therapies in Canada, an important market within the Company's growing global patent estate.

globenewswire.com2026-05-28

Aduro Clean Technologies to Participate in Industry and Investor Conferences in June 2026

LONDON, Ontario, May 28, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces its participation in several industry and investor conferences in June 2026.

globenewswire.com2026-05-26

Aduro Clean Technologies to Commence Trading on the Toronto Stock Exchange

LONDON, Ontario, May 26, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is pleased to announce that it received final approval to list its common shares on the Toronto Stock Exchange (“TSX”) under the symbol “ACT”. Trading on the TSX will commence at market open on May 27, 2026.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"ACT reported Q1 2026 revenue of $312.1M and net income of $167.8M, with EPS of $1.18. YoY, revenue increased +1.7% (from $306.9M in Q1’25) and net income rose +1.2% (from $165.8M). QoQ, revenue edged up +0.2% (from $311.5M in Q4’25) while net income declined -5.3% (from $177.2M), indicating earnings softness despite stable top-line. Profitability was resilient but mixed: net margin was 53.8% in Q1’26 versus 54.0% in Q1’25 (slightly contracting) and 56.9% in Q4’25 (contracting QoQ). Interest expense was broadly flat year-over-year, and the tax burden remained similar, supporting relatively stable earnings quality. Cash flow quality remained strong. Operating cash flow (OCF) was $224.0M and free cash flow (FCF) $224.0M, translating to meaningful cash generation versus net income. Shareholders were returned cash via buybacks ($93.2M) and dividends ($29.8M). Total shareholder returns look supportive: the stock is up 23.96% over 1 year (capital appreciation tailwind). Dividend yield is modest (~0.52%), so buybacks likely drive more of the return profile than yield. Balance sheet resilience is notable with substantial net cash (net debt is negative) and high equity ($5.34B) that stayed broadly stable versus Q4’25."

Revenue Growth

Positive

Revenue grew +1.7% YoY in Q1’26 ($312.1M vs $306.9M) and was nearly flat QoQ (+0.2% vs Q4’25).

Profitability

Positive

Net margin slightly contracted YoY (53.8% vs 54.0%) and more meaningfully QoQ (53.8% vs 56.9%). Net income rose +1.2% YoY but fell -5.3% QoQ.

Cash Flow Quality

Good

OCF/FCF remained strong: Q1’26 FCF was $224.0M. Capital returns continued with buybacks ($93.2M) and dividends ($29.8M).

Leverage & Balance Sheet

Good

Net cash position improved/remained strong (net debt -$549M) with total assets ~$6.96B and equity ~$5.34B, supporting downside resilience.

Shareholder Returns

Good

1Y price momentum is strong (+23.96%), lifting total return. Yield is modest (~0.52%), with buybacks providing additional shareholder support.

Analyst Sentiment & Valuation

Neutral

Consensus price target implies upside (current $42.89 vs target consensus $45; high/low $50/$40), but valuation appears richer on earnings multiples (P/E ~8.6).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Enact (ACT) delivered Q1’26 results driven by resilient credit fundamentals and disciplined capital/expense management despite volatile mortgage rates. Adjusted operating income was $172M ($1.21/share), with persistency steady at 80% and delinquencies improving sequentially (new delinquencies down; cures up to 54%). Loss ratio rose to 15% due to lower net reserve release versus prior periods, but management highlighted strong cure/loss mitigation and maintained claim-rate at 8%, leaving booking assumptions unchanged. Revenue durability was supported by constructive pricing via Rate360 (base premium rate 39.4 bps, net earned premium 34.3 bps; both slightly lower sequentially). Capital return accelerated: $123M returned in the quarter (repurchases plus dividends) and a 14% dividend increase to $0.24/share payable June 18. Management reaffirmed $215M–$220M expense guidance and ~ $500M total 2026 capital returns. Key watch items: Sunbelt home price moderation and potential modest delinquency uptick from aging purchase-heavy cohorts.

AI IconGrowth Catalysts

  • Rate360 dynamic risk-adjusted pricing enabling granular premium targeting amid volatile mortgage rates
  • Enact Re first-quarter performance supporting capital and diversification with attractive risk-adjusted returns
  • Elevated persistency (80%) and portfolio seasoning tailwind from loans with rates below 6% (58% of book)

Business Development

  • FHFA/GSE limited rollout of VantageScore 4.0 (operational readiness workstream; PMIERs guidance pending)
  • GSE execution in Q1 reportedly better than FHA execution, contributing to a Q1 uptick in MI penetration

AI IconFinancial Highlights

  • Adjusted operating income $172M / $1.21 per diluted share; vs $1.10 prior-year Q1 and $1.23 in Q4’25
  • Adjusted operating return on equity 12.9% (ROE 13% stated in prepared remarks)
  • New insurance written $13B: down 11% sequentially; up 30% year-over-year
  • Persistency 80%: flat sequentially; down 4 points year-over-year
  • Base premium rate 39.4 bps: down 0.2 bps sequentially
  • Net earned premium rate 34.3 bps: down 0.5 bps sequentially driven by higher ceded premiums
  • Investment income $71M: up $2M (3%) sequentially; up $8M (12%) year-over-year; new money yield 5%; average portfolio book yield 4.5%
  • Delinquencies: new delinquencies 13,600 (down 100 sequentially); new delinquency rate 1.5% flat sequentially; +20 bps vs Q1’25; cure rate 54% (+3 pts sequentially); total delinquencies 24,700 (down 200 sequentially) with delinquency rate 2.6% flat sequentially
  • Loss ratio 15% (vs 12% in Q4’25 and 7% in Q1’25); loss amount $37M vs $18M prior quarter
  • Net reserve release $39M driven by favorable cure/loss mitigation (vs $60M in Q4’25 including claim rate reduction 9% to 8% and vs $47M in Q1’25)
  • Operating expenses $49M; expense ratio 20% (vs 24% in Q4’25; vs 21% in Q1’25); full-year expense guidance reaffirmed $215M-$220M excluding reorganization costs

AI IconCapital Funding

  • Share repurchases: 2.3M shares at avg $40.66 for $93M during the quarter
  • Dividend: $30M paid ($0.21/share); Board approved 14% dividend increase to $0.24/share payable June 18, 2026
  • Additional buybacks through April 30: 0.7M shares for $30M
  • 2026 total capital return guidance: approximately $500M unchanged
  • PMIERs sufficiency ratio 162%; PMIERs capital credit from third-party CRT program $1.9B; undrawn credit facility cited as support

AI IconStrategy & Ops

  • Reiterated disciplined expense management and focus on operating efficiencies while investing for organic growth
  • Rate360 continues multiple-version iteration; investment for next generation includes machine learning and AI (no specific roadmap disclosed)
  • No operational impact beyond VantageScore 4.0 implementation readiness; awaiting PMIERs/FHFA/GSE guidance for FICO regime changes
  • Asset sales in quarter to recoup realized losses through higher future net investment income

AI IconMarket Outlook

  • Full-year 2026 operating expense guidance: $215M-$220M excluding reorganization costs
  • Management guided flattish base premium rate over full-year 2026 with quarter-to-quarter volatility
  • Dividend payable date: June 18, 2026
  • Conference dates referenced: May 7 (BTIG Housing Ecosystem Conference) and May 19 (KBW Real Estate Finance and Technology Conference)

AI IconRisks & Headwinds

  • Geography-specific home price moderation/declines tied to increased supply in Sunbelt markets (specifically Florida and Texas)
  • Mortgage rate volatility impacting application flows (refi slowdown as rates rose in March/April; spring selling season impact on purchase applications)
  • Delinquency rate could tick up modestly from Q1’26 levels due to aging of newer purchase-heavy books (higher LTV/DTI and lower FICO attributes), assuming macro remains broadly stable
  • Tariff-driven uncertainty and labor-market/inflation pressures (gas prices cited as accelerating inflation); management referenced reserving methods and maintained no change to booking assumptions on new delinquencies during the quarter

Q&A: Analyst Interest

  • Credit/geography pricing: Management stated performance remains strong versus pricing expectations, but noted supply-driven home price moderation in the Sunbelt (Florida/Texas). They emphasized Rate360’s ability to price across 300+ MSAs using a forward home-price view, charging incremental premium where markets are more likely to pull back.
  • PMIERs and VantageScore rollout: Management said they support VantageScore 4.0 initiatives and are operationally ready, but PMIERs must be revisited once guidance arrives. They will incorporate PMIERs guidance into return calculations for Rate360 loan cohorts, generating score-specific pricing; same intent with future FICO 10.
  • Delinquency and premium yield outlook: Management guided that delinquency rate could tick up from Q1’s 2.6% due to aging purchase-heavy books (higher LTV/DTI, lower FICO), but stressed macro, NIW levels, and claim timing make precision difficult. For pricing, they expected flattish base premium rate over 2026 amid mix-driven quarter volatility.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the ACT Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for ACT.

SEC EDGAR Live Feed
No recent 10-K available.
No recent 10-Q available.
Loading financial data and tables...
📁

SEC Filings (ACT)

© 2026 Stock Market Info — Enact Holdings Inc. (ACT) Financial Profile